Related Experiment Video
Updated: May 27, 2026

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
Late-stage modification of the alkaloid toxin veratridine to photocontrol excitable tissues
Luisa Camerin1, Galyna Maleeva2, Ailín Ramírez-Abreu3
1Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), Spain; Networking Biomedical Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), ISCIII, Spain; Doctorate program in Organic Chemistry, University of Barcelona, Spain.
Abstract:
Natural products and their structural derivatives have long played a crucial role in the discovery of new medical treatments and pharmacotherapies. However, certain natural compounds, such as toxins, are classified as hazardous substances that pose risk to human health. It is desirable to modulate the activity of toxins to minimize their harmful effects and unleash their potential as selective and bioavailable drugs. Yet, the functionalization of natural products remains a challenge due to their structural complexity. Here, we present two methods for late-stage C-H nitration and subsequent derivatization of the alkaloid steroidal neurotoxin veratridine, a sodium channel opener, by introducing an azobenzene photoswitch in its structure. The resulting compound, Azoveratridine, displays aqueous solubility, reversible photoisomerization, and light-dependent activity in neurons and myocardial slices.

